275 related articles for article (PubMed ID: 26148677)
1. An NKX3.1 binding site polymorphism in the l-plastin promoter leads to differential gene expression in human prostate cancer.
Chen C; Cai Q; He W; Li Z; Zhou F; Liu Z; Zhong G; Chen X; Zhao Y; Dong W; Huang J; Zheng J; Lin T
Int J Cancer; 2016 Jan; 138(1):74-86. PubMed ID: 26148677
[TBL] [Abstract][Full Text] [Related]
2. [Identification of response element gene sequence for non-steroid hormone transcription factors for the activation and up-regulation of L-plastin expression in prostate cancer].
Lin TX; Huang J; Huang H; Cai QQ; Xu KW; Yin XB; Jiang C
Zhonghua Nan Ke Xue; 2005 Oct; 11(10):731-4. PubMed ID: 16281503
[TBL] [Abstract][Full Text] [Related]
3. AP4 modulated by the PI3K/AKT pathway promotes prostate cancer proliferation and metastasis of prostate cancer via upregulating L-plastin.
Chen C; Cai Q; He W; Lam TB; Lin J; Zhao Y; Chen X; Gu P; Huang H; Xue M; Liu H; Su F; Huang J; Zheng J; Lin T
Cell Death Dis; 2017 Oct; 8(10):e3060. PubMed ID: 28981098
[TBL] [Abstract][Full Text] [Related]
4. Identification of an inhibitory cis-element in the promoter region of human homeobox gene NKX3.1.
Anli J; Pengju Z; Xiaoyan H; Wenwei C; Zhifang L; Feng K; Huiqing Y; Jianye Z
Prostate; 2006 Sep; 66(12):1339-46. PubMed ID: 16845664
[TBL] [Abstract][Full Text] [Related]
5. Androgen regulation of the prostatic tumour suppressor NKX3.1 is mediated by its 3' untranslated region.
Thomas MA; Preece DM; Bentel JM
Biochem J; 2010 Jan; 425(3):575-83. PubMed ID: 19886863
[TBL] [Abstract][Full Text] [Related]
6. Loss of the NKX3.1 tumorsuppressor promotes the TMPRSS2-ERG fusion gene expression in prostate cancer.
Thangapazham R; Saenz F; Katta S; Mohamed AA; Tan SH; Petrovics G; Srivastava S; Dobi A
BMC Cancer; 2014 Jan; 14():16. PubMed ID: 24418414
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of L-plastin gene by testosterone in breast and prostate cancer cells: identification of three cooperative androgen receptor-binding sequences.
Lin CS; Lau A; Yeh CC; Chang CH; Lue TF
DNA Cell Biol; 2000 Jan; 19(1):1-7. PubMed ID: 10668786
[TBL] [Abstract][Full Text] [Related]
8. Effects of 9-cis retinoic acid on human homeobox gene NKX3.1 expression in prostate cancer cell line LNCaP.
Jiang AL; Zhang PJ; Chen WW; Liu WW; Yu CX; Hu XY; Zhang XQ; Zhang JY
Asian J Androl; 2006 Jul; 8(4):435-41. PubMed ID: 16763719
[TBL] [Abstract][Full Text] [Related]
9. A functional variant in NKX3.1 associated with prostate cancer susceptibility down-regulates NKX3.1 expression.
Akamatsu S; Takata R; Ashikawa K; Hosono N; Kamatani N; Fujioka T; Ogawa O; Kubo M; Nakamura Y; Nakagawa H
Hum Mol Genet; 2010 Nov; 19(21):4265-72. PubMed ID: 20716579
[TBL] [Abstract][Full Text] [Related]
10. Occurrence of NKX3.1 C154T polymorphism in men with and without prostate cancer and studies of its effect on protein function.
Gelmann EP; Steadman DJ; Ma J; Ahronovitz N; Voeller HJ; Swope S; Abbaszadegan M; Brown KM; Strand K; Hayes RB; Stampfer MJ
Cancer Res; 2002 May; 62(9):2654-9. PubMed ID: 11980664
[TBL] [Abstract][Full Text] [Related]
11. p53 overexpression represses androgen-mediated induction of NKX3.1 in a prostate cancer cell line.
Jiang A; Yu C; Zhang P; Chen W; Liu W; Hu X; Zhang J
Exp Mol Med; 2006 Dec; 38(6):625-33. PubMed ID: 17202838
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional regulation of the homeobox gene NKX3.1 by all-trans retinoic acid in prostate cancer cells.
Thomas MA; Hodgson MC; Loermans SD; Hooper J; Endersby R; Bentel JM
J Cell Biochem; 2006 Dec; 99(5):1409-19. PubMed ID: 16817226
[TBL] [Abstract][Full Text] [Related]
13. Risk SNP-Mediated Promoter-Enhancer Switching Drives Prostate Cancer through lncRNA PCAT19.
Hua JT; Ahmed M; Guo H; Zhang Y; Chen S; Soares F; Lu J; Zhou S; Wang M; Li H; Larson NB; McDonnell SK; Patel PS; Liang Y; Yao CQ; van der Kwast T; Lupien M; Feng FY; Zoubeidi A; Tsao MS; Thibodeau SN; Boutros PC; He HH
Cell; 2018 Jul; 174(3):564-575.e18. PubMed ID: 30033362
[TBL] [Abstract][Full Text] [Related]
14. Identification of Sp1-elements in the promoter region of human homeobox gene NKX3.1.
Yu CX; Jin T; Chen WW; Zhang PJ; Liu WW; Guan HY; Zhang J; Liu QW; Jiang AL
Mol Biol Rep; 2009 Nov; 36(8):2353-60. PubMed ID: 19263243
[TBL] [Abstract][Full Text] [Related]
15. Integration of regulatory networks by NKX3-1 promotes androgen-dependent prostate cancer survival.
Tan PY; Chang CW; Chng KR; Wansa KD; Sung WK; Cheung E
Mol Cell Biol; 2012 Jan; 32(2):399-414. PubMed ID: 22083957
[TBL] [Abstract][Full Text] [Related]
16. Germ-line mutation of NKX3.1 cosegregates with hereditary prostate cancer and alters the homeodomain structure and function.
Zheng SL; Ju JH; Chang BL; Ortner E; Sun J; Isaacs SD; Sun J; Wiley KE; Liu W; Zemedkun M; Walsh PC; Ferretti J; Gruschus J; Isaacs WB; Gelmann EP; Xu J
Cancer Res; 2006 Jan; 66(1):69-77. PubMed ID: 16397218
[TBL] [Abstract][Full Text] [Related]
17. The loss of NKX3.1 expression in testicular--and prostate--cancers is not caused by promoter hypermethylation.
Lind GE; Skotheim RI; Fraga MF; Abeler VM; Henrique R; Saatcioglu F; Esteller M; Teixeira MR; Lothe RA
Mol Cancer; 2005 Feb; 4(1):8. PubMed ID: 15691383
[TBL] [Abstract][Full Text] [Related]
18. ETS1 regulates NKX3.1 5' promoter activity and expression in prostate cancer cells.
Preece DM; Harvey JM; Bentel JM; Thomas MA
Prostate; 2011 Mar; 71(4):403-14. PubMed ID: 20842667
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the human L-plastin gene promoter in normal and neoplastic cells.
Lin CS; Chen ZP; Park T; Ghosh K; Leavitt J
J Biol Chem; 1993 Feb; 268(4):2793-801. PubMed ID: 8428953
[TBL] [Abstract][Full Text] [Related]
20. The murine L-plastin gene promoter: identification and comparison with the human L-plastin gene promoter.
Lin CS; Chang CH; Huynh T
DNA Cell Biol; 1997 Jan; 16(1):9-16. PubMed ID: 9022040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
